Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 25, 2017 12:48 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Launches Entry into Comprehensive Hereditary Cancer Testing for Breast & Ovarian Cancers, Addressing a $2.5 Billion Market

CGI believes that hereditary cancer testing will generate significant additional revenue from both clinical and biopharma customers during 2017 and beyond.Launch of hereditary panel, branded...
January 17, 2017 09:31 ET | Source: Cancer Genetics, Inc.

Precision Oncology Diagnostics Leader, Cancer Genetics, Inc. & Precision Therapeutics Company, Lantern Pharma, Inc. Announce Strategic Collaboration Focused on Drug Rescue & Repurposing Leveraging Genomics, Biomarkers & Artificial Intelligence Driven Development for Multiple Lead Oncology Compounds

The collaboration will leverage CGI’s biomarker discovery, clinical trial testing, and companion diagnostic development capabilities along with Lantern’s artificial intelligence and big-data driven...
January 09, 2017 09:27 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Announces Multiple Agreements & Collaborations to Develop Liquid Biopsy Programs with Leading Biopharma Companies

CGI has signed five agreements and contracts to develop focused, high-performance liquid biopsy tests for a broad range of solid tumorsThe liquid biopsy tests are focused on therapy monitoring &...
January 06, 2017 17:34 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Announces Consolidation and Cost Reduction in Administrative and Operational Support Functions

RUTHERFORD, N.J., Jan. 06, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) an emerging leader in enabling precision medicine for oncology through the use of molecular markers and...
December 22, 2016 17:40 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Registers Shares Underlying Existing Warrants; No Change in Fully Diluted Share Count

RUTHERFORD, N.J., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) an emerging leader in enabling precision medicine for oncology through the use of molecular markers and...
December 07, 2016 07:53 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Is Selected by BeiGene, Ltd. to Collaborate on Clinical Trial Services & Advance Portfolio of Novel Oncology Therapeutics

RUTHERFORD, N.J., Dec. 07, 2016 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or “The Company”), a leader in enabling precision medicine for oncology through molecular...
December 05, 2016 08:14 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Listed by Merck as a National Reference Laboratory for KEYTRUDA® (pembrolizumab) Companion Diagnostic Testing

Reinforces CGI’s Position as a Leader in Immuno-Oncology & Companion Diagnostics For PD-L1 Testing & MonitoringCompany Expects Significant Growth in Comprehensive Molecular & Immune...
December 01, 2016 09:20 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. and Leading Collaborators to Present Innovative Insights That Will Advance Precision Medicine in Diffuse Large B-cell Lymphoma (DLBCL) at American Society of Hematology (ASH) Annual Meeting 2016

The two studies presented at ASH highlight new data on genomic and immune biomarkers, as well as biological pathways of the aggressive cancer diffuse large B-cell lymphoma (DLBCL), the most common...
November 16, 2016 16:01 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Ranked Among Fastest Growing Companies For Third Consecutive Year By Deloitte’s Technology Fast 500™ - Ranks 233 in 2016

RUTHERFORD, N.J., Nov. 16, 2016 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in enabling precision medicine for oncology through the use of molecular markers and...
November 10, 2016 07:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Announces Strong Third Quarter with 68% Year Over Year Revenue Growth and Highlights Path to Future Profitability

Company reports third quarter revenues of $6.8 Million, an increase of 68% over the third quarter of 2015The revenue growth rate was 58% for the first 9 months of 2016 as compared to...